Blog
964 Articles
Standard Chemotherapy Plus Novel Drugs for Advanced Pancreatic Cancer
This trial tests the effectiveness of three different novel drugs, including immunotherapy, added to standard treatment for advanced pancreatic cancer.
COVID-19—An Update
What is the status of international and US travel? Which states have mask mandates? Are vaccines progressing? Read our COVID-19 update for more information.
Let’s Win! Pancreatic Cancer Foundation Appoints Two New Board Members
David Glauber and Sergeant Elvin Howard, Jr., have been appointed to the Let’s Win Board of Directors, effective July 2020.
NALIRIFOX Shows Promise in Early Studies
Dr. Zev Wainberg describes the new combination NALIRIFOX, being tested in the NAPOLI-3 clinical trial for advanced pancreatic cancer patients.
Planning Every Day to Live
Tammy Richardson has focused her pancreatic cancer treatment choices on maintaining her quality of life, so she can travel and see family.
Individuals Can Make a Difference
As a long-term survivor of pancreatic cancer Diane Borrison realized that it was important for her to become a committed advocate for this disease.
At the Table: Taking Care During the COVID-19 Pandemic
Pancreatic cancer survivors discuss the different ways they are being careful to avoid catching COVID-19 during the pandemic.
Canadian Study NeoPancONE Focuses on Biomarker Validation
Dr. Jennifer Knox is leading the NeoPancONE trial for a biomarker that indicates which patients will respond better to certain chemotherapy before surgery.
Working Hard to Beat Pancreatic Cancer
Sandy Robis underwent a full pancreatectomy and chemotherapy to help her beat pancreatic cancer. Now she helps support other patients.
Slowing the Spread of Advanced Pancreatic Cancer
Researchers are testing a kinase inhibitor that is used to treat lung diseases, including a type of lung cancer, against pancreatic cancer.
GENERATE Trial Expands Eligibility
Dr. Sapna Syngal explains the expanded eligibility standards for the GENERATE Study for genetic testing of pancreatic cancer patients and relatives.
Planning for My Future
When diagnosed with Stage IV PNET at the age of 30, Amy Zaterman found a doctor who believed in her and didn’t give up. Learn more about her inspiring story.
At the Table: How to Talk to your Family and Friends about Pancreatic Cancer
David Dessert, Miggie Olsson, and John Moisan share what they learned about how to talk to family and friends about pancreatic cancer.
DIRECT Study Focuses on NanoKnife Technology
Dr. Daniel Holzwanger is part of the NanoKnife irreversible electroporation (IRE) study for stage III pancreatic cancer patients.
You Can Beat the Odds
Richard Blish, a long-term survivor of pancreatic cancer, was directed to a clinical trial by his immunologist daughter. The trial saved his life.